Prognostic value of persistent peripheral blood and bone marrow lymphoblasts on day 15 of therapy in childhood acute lymphoblastic leukemia as detected by flow cytometry

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1453-1457

  Jaworska Posadzy, Anna ^a   Styczynski, Jan ^a   Kubicka, Malgorzata ^a   Debski, Robert ^a   Rafinska Kurylo, Beata ^a   Kolodziej, Beata ^a   Pogorzala, Monika ^a   Wysocki, Mariusz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Acute lymphoblastic leukemia; Children; Early response; Flow cytometry; Minimal residual disease

Indexed keywords

ABSOLUTE BLAST COUNT; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD; BONE MARROW; CELL COUNT; CHILD; CHILDHOOD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORPHOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RELAPSE; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; BLAST CRISIS; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; YOUNG ADULT;

EID: 79956161045     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, Benetello A, Buldini B, Maglia O, Masera G, Conter V, Arico M, Biondi A and Gaipa G: Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol 27: 5168-5174, 2009.
2. Mejstrikova E, Fronkova E, Kalina T, Omelka M, Batinic D, Dubravcic K, Pospisilova K, Vaskova M, Luria D, Cheng SH, Ng M, Leung Y, Kappelmayer J, Kiss F, Izraeli S, Stark B, Schrappe M, Trka J, Stary J and Hrusak O: Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry. Pediatr Blood Cancer 54: 62-70, 2010.
3. Szczepanski T, Orfao A, van der Velden VH, San Miguel JF and van Dongen JJ: Minimal residual disease in leukaemia patients. Lancet Oncol 2: 409-417, 2001. (Pubitemid 33585945)
4. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollmann B and Henze G: Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 199: 151-160, 1987.
5. Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG and Uckun FM: Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer 80: 1717-1726, 1997. (Pubitemid 27475928)
6. Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, Loning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Weite K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H and Schrappe M: Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111: 4477-4489, 2008.
7. Morimoto A, Kuriyama K, Hibi S, Todo S, Yoshihara T, Kuroda H and Mashuku S: Prognostic value of early response to treatment combined with conventional risk factors in pediatric acute lymphoblastic leukemia. Int J Hematol 81: 228-234, 2005. (Pubitemid 41364488)
8. Ratei R, Basso G, Dworzak M, Gaipa G, Veltroni M, Rhein P, Biondi A, Schrappe M, Ludwig WD and Karawajew L: Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: Predictive impact of early blast reduction on the remission status after induction. Leukemia 23: 528-534, 2009.
9. van der Velden VH, Panzer-Grumayer ER, Cazzaniga G, Flohr T, Sutton R, Schrauder A, Basso G, Schrappe M, Wijkhuijs JM, Konrad M, Bartram CR, Masera G, Biondi A and van Dongen JJ: Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 27: 706-713, 2007. (Pubitemid 46444554)
10. Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, Arico M, Zimmermann M, Mann G, De Rossi G, Stanulla M, Locatelli F, Basso G, Niggli F, Barisone E, Henze G, Ludwig WD, Haas OA, Cazzaniga G, Koehler R, Silvestri D, Bradtke J, Parasole R, Beier R, van Dongen JJ, Biondi A and Schrappe M: Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 775: 3206-3214, 2010.
11. Coustan-Smith E, Ribeiro RC, Stow P, Zhou Y, Pui CH, Rivera GK, Pedrosa F and Campana D: A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood 108: 97-102, 2006. (Pubitemid 43990616)
12. Coustan-Smith E, Sancho J, Behm FG, Hancock ML, Razzouk BI, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Pui CH and Campana D: Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 100: 52-58, 2002. (Pubitemid 35177428)
13. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Weite K, Gadner H and Riehm H: Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM study group. Blood 95: 3310-3322, 2000.
14. Pui CH, Pei D, Sandlund JT, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Campana D, Kun LE, Jeha S, Cheng C, Howard SC, Metzger ML, Bhojwani D, Downing JR, Evans WE and Relling MV: Long-term results of St. Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24: 371-382, 2010.
15. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, Klingebiel T, Zintl F, Niemeyer C, Kremens B, Niggli F, Niethammer D, Weite K, Stanulla M, Odenwald E, Riehm H and Schrappe M: Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24: 265-284, 2010.
16. Conter V, Arico M, Basso G, Biondi A, Barisone E, Messina C, Parasole R, De Rossi G, Locatelli F, Pession A, Santoro N, Micalizzi C, Citterio M, Rizzari C, Silvestri D, Rondelli R, Lo Nigro L, Ziino O, Testi AM, Masera G and Valsecchi MG: Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 24: 255-264, 2010.
17. Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O, Karawajew L, Benetello A, Potschger U, Husak Z, Gadner H, Biondi A, Ludwig WD and Basso G: Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible. Cytometry B Clin Cytom 74: 331-340, 2008.
18. Lorenzana R, Coustan-Smith E, Antillon F, Ribeiro RC and Campana D: Simple methods for the rapid exchange of flow cytometric data between remote centers. Leukemia 74: 336-337, 2000. (Pubitemid 30095392)
19. Pui CH: Toward a total cure for acute lymphoblastic leukemia. J Clin Oncol 27: 5121-5123, 2009.
20. Zweidler-McKay P, Gramatges MM, Borowitz M, Palla S, Shi X, Margolin J and Rabin K: Refining MRD-based risk stratification in pediatric ALL using absolute lymphocyte counts (abstract 301b). Pediatr Blood Cancer 54: 788, 2010.